Customizable nanoparticle subunit vaccines for mass administration in drinking water

Overview

Multispec Bio presents an innovative nanoparticle-based subunit vaccine platform designed for rapid and customizable vaccine development against various serotypes. The platform leverages cell-free protein synthesis and nanoparticle conjugation technologies to create virus-like-particle vaccines, enhancing immunogenicity. This unique approach allows for the storage of vaccine components at room temperature and finalizes manufacturing at the point-of-use, making it ideal for mass administration scenarios such as in drinking water for poultry.

Technical specifications

The core technological innovation lies in the ability to rapidly attach subunit vaccines onto nanoparticle surfaces. This is achieved through a cell-free expression system that enables easy customization by simply altering the DNA template. The nanoparticles can be engineered for stability in complex environments, facilitating their deployment in drinking water or feed. The platform supports multiplex vaccination, enabling a single solution to address multiple serotypes by incorporating various antigens. Future efforts include optimizing lipid nanoparticle formulations for stability, safety, and maximal immune response in poultry, alongside large-scale manufacturing processes.

Technology readiness level

Currently at Technology Readiness Level 2, the platform has demonstrated proof-of-concept in mice for the Nipah virus. Future validation aims include developing a nanoparticle vaccine for poultry, demonstrating robust immune responses, and scaling up manufacturing for larger trials.